Dosage information was updated.
Drugs & Treatments
Every drug, with the intelligence behind it.
Branded and generic drug pages, classes, indications, and the literature that backs them.
Popular
Make this page yours.
Sign in to see your saved drugs, updates on them, and your specialty’s top drugs — right here, every time you visit.
New in Drugs
Approvals, biosimilars & label changes.
Generic dosing information was updated.
Brand dosing information was updated.
Dosage information was updated.
News & Articles
Coverage tied to specific drugs.
Most-read drug coverage this week.
NEJM
Head-to-head data: adalimumab biosimilars hold equivalence in elderly cohorts
A phase IV study compares Humira, Hadlima, and Hyrimoz across PK endpoints in patients aged 65+.
FDA
Label update: Monjuvi safety information revised for cytopenia monitoring
Clarified monitoring guidance for prolonged cytopenias during R-CHOP combination therapy in DLBCL.
JAMA
JAK inhibitor MACE risk: what the latest registry analysis changes
A large observational cohort refines cardiovascular risk stratification for tofacitinib and upadacitinib.
Browse all drugs
Start where you think — class, indication, or maker.
Popular classes
Protein Kinase Inhibitors...
Antirheumatic Agents (Bio...
Chromium
Topical Sulfonamide Antim...
Antidepressant Serotonin-...
By drug classClasses, grouped by family
By indicationIndications, by specialty
By manufacturerMakers, A–Z
Browse all drugs
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Personalize your experience
Get your specialty’s drug intelligence every morning.
Create a free account
Already a member? Sign in
Save any drug and get change alerts when its label or safety data updates
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of brand- and indication-relevant updates, when you want it
Your full viewing history, saved and synced across every device